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Introduction
Identifying patients who may deteriorate on the ward
and need admission to an intensive care unit (ICU) is
imprecise. Numerous variables, alone or in combination,
have been used to identify patients who may benefit from
ICU admission. A predictive test should be accurate,
reliable, easy to measure and cheap. [1]
15 years ago an observational study from our unit
showed that both base excess (BE) and lactate, or combi-
nation of both, can be used to predict outcome in patients
admitted to ITU [2]. We replicated this study to find out if
BE and lactate are still useful prognostic indicators for
patients admitted to ITU.
Methods
As in the 2001 study we examined the records of 148
unselected, consecutive general medical and surgical
admissions to St George’s Hospital General ITU in
September 2013. We recorded blood BE and lactate levels
at admission and at 24 hours and calculated corresponding
Sequential Organ Failure Assessment (SOFA) scores. The
data was taken from the patients’ ITU charts and our
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Figure 1 Overview of lactate and base excess.
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computer laboratory result system EPR. We compared this
data to that presented in 2001. The chi square test was
used to determine the statistical difference between
groups.
Results
44 patients were admitted with acute medical problems,
68 after elective surgery and 36 after emergency surgery
(compared with 70, 53 and 25 respectively in reported in
2001). As in 2001 we divided the patients into three
groups: those with admission serum lactate ≥ 1.5 or < 1.5
mmol/l, those with serum BE > -4.0 or ≤ -4.0 mmol/l and
those with admission BE ≤ -4.0 mmol/l and a lactate
≥1.5mmol/l. Calculated admission SOFA scores were not
significantly different between and of the 2001 and 2014
groups.
Patients with a deranged admission lactate had a mortal-
ity of 10%, versus 4.4% in the normal lactate group. If the
lactate failed to clear at 24 hours, mortality was 32% versus
2% if it had cleared. Similarly, patients admitted with a BE
≤ -4.0 mmol/l had a mortality of 15% compared to 4% in
patients with a BE >-4mmol/l. If BE was still ≤ -2.5 mmol/
l at 24 hours, mortality was 25% versus 0% if the base defi-
cit had improved. A combination of deranged lactate and
BE ≤ -4.0 mmol/l showed a mortality of 17% and 33% if it
had failed to clear at 24 hours. (Table 1).
Conclusions
Base excess and lactate are still indicators of severity of
disease and can be used to monitor treatment and
response.
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